Cost-Effectiveness of Universal or High-Risk Screening Compared to Surveillance Monitoring in Autism Spectrum Disorder / T. YUEN in Journal of Autism and Developmental Disorders, 48-9 (September 2018)  

Public ISBD [article]  inJournal of Autism and Developmental Disorders > 48-9 (September 2018) . - p.2968-2979 Titre : Cost-Effectiveness of Universal or High-Risk Screening Compared to Surveillance Monitoring in Autism Spectrum Disorder Type de document : Texte imprimé et/ou numérique Auteurs : T. YUEN, Auteur ; M. T. CARTER, Auteur ; P. SZATMARI, Auteur ; W. J. UNGAR, Auteur Article en page(s) : p.2968-2979 Langues : Anglais (eng) Mots-clés : Autism spectrum disorder  Cost-effectiveness analysis  Health services research  Screening Index. décimale : PER Périodiques Résumé : The American Academy of Pediatrics recommends universal screening for autism spectrum disorder at 18 and 24 months. This study compared the cost-effectiveness of universal or high-risk screening to surveillance monitoring. Simulation models estimated the costs and outcomes from birth to age 6 years. The incremental cost per child diagnosed by 36 months was $41,651.6 for high-risk screening and $757,116.9 for universal screening from the societal perspective. Universal screening may not be a cost-effective approach to increase earlier treatment initiation, as most children initiated treatment after age 60 months. Eliminating wait times resulted in more children initiated treatment by 48 months, but at a high initial cost that may be offset by future cost-savings related to better outcomes. En ligne : http://dx.doi.org/10.1007/s10803-018-3571-4 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=367 [article] Cost-Effectiveness of Universal or High-Risk Screening Compared to Surveillance Monitoring in Autism Spectrum Disorder [Texte imprimé et/ou numérique] / T. YUEN, Auteur ; M. T. CARTER, Auteur ; P. SZATMARI, Auteur ; W. J. UNGAR, Auteur . - p.2968-2979. Langues : Anglais (eng) in Journal of Autism and Developmental Disorders > 48-9 (September 2018) . - p.2968-2979 Mots-clés : Autism spectrum disorder  Cost-effectiveness analysis  Health services research  Screening Index. décimale : PER Périodiques Résumé : The American Academy of Pediatrics recommends universal screening for autism spectrum disorder at 18 and 24 months. This study compared the cost-effectiveness of universal or high-risk screening to surveillance monitoring. Simulation models estimated the costs and outcomes from birth to age 6 years. The incremental cost per child diagnosed by 36 months was $41,651.6 for high-risk screening and $757,116.9 for universal screening from the societal perspective. Universal screening may not be a cost-effective approach to increase earlier treatment initiation, as most children initiated treatment after age 60 months. Eliminating wait times resulted in more children initiated treatment by 48 months, but at a high initial cost that may be offset by future cost-savings related to better outcomes. En ligne : http://dx.doi.org/10.1007/s10803-018-3571-4 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=367

---

1 (1 - 1 / 1)